Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Victoria: mRNA Technology for Healthcare Innovation

The government in Victoria is heavily investing in the advancement of cutting-edge mRNA technology for vaccines and medical treatments, cultivating an innovation industry that both generates employment opportunities and offers transformative healthcare solutions to the people of Victoria.

The region’s Minister for Economic Growth has officially initiated the application process for Round 3 of the mRNA Victoria Research Acceleration Fund, which provides grants to eligible research teams and biotech startups.

These grants are designed to support research teams in the development of innovative RNA and mRNA-based therapeutics. Biotech startups can receive up to AU$500,000 to expedite the translation of research, while research teams engaged in early-stage investigations can access grants of up to AU$100,000.

Since its inception, the Labor Government’s mRNA Victoria initiative has sponsored 42 research projects, with a total investment exceeding AU$27 million. This funding has been instrumental in unlocking novel mRNA treatments and vaccines for conditions such as muscular dystrophy, Alzheimer’s disease, and challenging cancers.

mRNA technology represents the future of medical research and has gained significant recognition, with Katalin Kariko and Drew Weissman being awarded the 2023 Nobel Prize for Physiology and Medicine for their groundbreaking work in this field.

Victoria is at the forefront of mRNA technology development in Australia. The construction of a US-based pharmaceutical and biotechnology company’s mRNA vaccine manufacturing facility in Clayton is progressing, with plans to produce 100 million mRNA vaccine doses annually once operational.

Melbourne serves as the hub for the biotech firm’s activities in Australia, New Zealand, South-East Asia, and Oceania, and it recently established the firm’s Regional Research Centre for Respiratory Medicines and Tropical Diseases, fostering collaboration with Australian medical researchers on innovative mRNA therapeutics.

Furthermore, the Labor Government has allocated AU$10 million to establish the Monash Centre for Advanced mRNA Medicines Manufacturing and Workforce Training, a dedicated facility that trains the future workforce of the Asia-Pacific region in mRNA therapeutic development and advanced manufacturing.

Victoria has a crucial role in Australia’s pharmaceutical exports, accounting for nearly 60% of the country’s pharmaceutical exports. This industry is the highest-value advanced manufacturing sector, supporting over 100,000 full-time jobs in biotechnology.

The Minister for Economic Growth in Victoria noted that in the realm of technology-driven innovation, mRNA stands as an exciting and burgeoning element, presenting immediate employment prospects and vast future potential. The effective collaboration between industry and researchers enables the harnessing of mRNA and advanced manufacturing capabilities, resulting in the development of pioneering vaccines and medications.

The region’s Minister for Medical Research stated that the committed and highly skilled medical researchers in Victoria are making noteworthy contributions to technological progress, which is leading to significant advancements in healthcare and the preservation of lives. There is a strong sense of pride in providing support for their essential initiatives.

OpenGov Asia reported earlier that The School of Chemical Engineering at the University of Adelaide will contribute to the development of cutting-edge technology aimed at creating tailored mRNA-based drugs and vaccines. This technology will be established and used in Adelaide, positioning the city as a leader in this field.

The University of Adelaide has partnered with a multi-product biologics contract development and manufacturing organisation (CDMO) to advance ground-breaking technology in precision medicine manufacturing, as well as manufacturing processes. This partnership will enable the implementation of these technologies at the company’s Adelaide facility.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.